F-star Therapeutics (NASDAQ:FSTX) soared 18% after announcing that it's extended the termination date for its planned merger with invoX
https://seekingalpha.com/news/3940154-f-star-therapeutics-jumps-as-it-extends-walk-date-with-buyer-to-finalize-cfius-agreement
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.